Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors.
F Fais, … , M Ferrarini, N Chiorazzi
F Fais, … , M Ferrarini, N Chiorazzi
Published October 15, 1998
Citation Information: J Clin Invest. 1998;102(8):1515-1525. https://doi.org/10.1172/JCI3009.
View: Text | PDF
Research Article Article has an altmetric score of 9

Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors.

  • Text
  • PDF
Abstract

To better understand the stage(s) of differentiation reached by B-type chronic lymphocytic leukemia (B-CLL) cells and to gain insight into the potential role of antigenic stimulation in the development and diversification of these cells, we analyzed the rearranged VH genes expressed by 83 B-CLL cells (64 IgM+ and 19 non-IgM+). Our results confirm and extend the observations of a bias in the use of certain VH, D, and JH genes among B-CLL cells. In addition, they indicate that the VH genes of approximately 50% of the IgM+ B-CLL cells and approximately 75% of the non-IgM+ B-CLL cells can exhibit somatic mutations. The presence of mutation varies according to the VH family expressed by the B-CLL cell (VH3 expressers displaying more mutation than VH1 and VH4 expressers). In addition, the extent of mutation can be sizeable with approximately 32% of the IgM+ cases and approximately 68% of the non-IgM+ cases differing by > 5% from the most similar germline gene. Approximately 20% of the mutated VH genes display replacement mutations in a pattern consistent with antigen selection. However, CDR3 characteristics (D and JH gene use and association and HCDR3 length, composition, and charge) suggest that selection for distinct B cell receptors (BCR) occurs in many more B-CLL cells. Based on these data, we suggest three prototypic BCR, representing the VH genes most frequently encountered in our study. These data suggest that many B-CLL cells have been previously stimulated, placing them in the "experienced" or "memory" CD5(+) B cell subset.

Authors

F Fais, F Ghiotto, S Hashimoto, B Sellars, A Valetto, S L Allen, P Schulman, V P Vinciguerra, K Rai, L Z Rassenti, T J Kipps, G Dighiero, H W Schroeder Jr, M Ferrarini, N Chiorazzi

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1981 Total
Citations: 2 7 9 10 28 16 11 17 25 18 27 25 48 29 37 31 33 30 36 37 33 35 32 29 30 26 12 1 674
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2008 (30)

Title and authors Publication Year
A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies
AL Myhrinder, E Hellqvist, E Sidorova, A Soderberg, H Baxendale, C Dahle, K Willander, G Tobin, E Backman, O Soderberg, R Rosenquist, S Horkko, A Rosen
Blood 2008
Chronic lymphocytic leukemia antibodies with a common stereotypic rearrangement recognize nonmuscle myosin heavy chain IIA
CC Chu, R Catera, K Hatzi, XJ Yan, L Zhang, XB Wang, HM Fales, SL Allen, JE Kolitz, KR Rai, N Chiorazzi
Blood 2008
Nonstochastic pairing of immunoglobulin heavy and light chains expressed by chronic lymphocytic leukemia B cells is predicated on the heavy chain CDR3
GF 2nd, CJ Goldberg, TL Toy, LZ Rassenti, WG Wierda, JC Byrd, MJ Keating, JG Gribben, KR Rai, TJ Kipps
Blood 2008
Evidence for the significant role of immunoglobulin light chains in antigen recognition and selection in chronic lymphocytic leukemia
A Hadzidimitriou, N Darzentas, F Murray, T Smilevska, E Arvaniti, C Tresoldi, A Tsaftaris, N Laoutaris, A Anagnostopoulos, F Davi, P Ghia, R Rosenquist, K Stamatopoulos, C Belessi
Blood 2008
Chronic Lymphocytic Leukemia Cells Recognize Conserved Epitopes Associated with Apoptosis and Oxidation
R Catera, GJ Silverman, K Hatzi, T Seiler, S Didier, L Zhang, M Hervé, E Meffre, DG Oscier, H Vlassara, RH Scofield, Y Chen, SL Allen, J Kolitz, KR Rai, CC Chu, N Chiorazzi
Molecular Medicine 2008
Microenvironmental influences in chronic lymphocytic leukaemia: the role of antigen stimulation
P Ghia, N Chiorazzi, K Stamatopoulos
Journal of Internal Medicine 2008
Farnesyl transferase inhibitors induce extended remissions in transgenic mice with mature B cell lymphomas
KA Field, S Charoenthongtrakul, JM Bishop, Y Refaeli
Molecular Cancer 2008
FCRL2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemia
FJ Li, S Ding, J Pan, MA Shakhmatov, E Kashentseva, J Wu, Y Li, S Soong, N Chiorazzi, RS Davis
Blood 2008
Analysis of CD23 antigen expression in B-chronic lymphocytic leukaemia and its correlation with clinical parameters
V Jurisic, N Colovic, N Kraguljac, HD Atkinson, M Colovic
Medical Oncology 2008
Relevance of the immunoglobulin VH somatic mutation status in patients with chronic lymphocytic leukemia treated with fludarabine, cyclophosphamide, and rituximab (FCR) or related chemoimmunotherapy regimens
KI Lin, CS Tam, MJ Keating, WG Wierda, S O'Brien, S Lerner, KR Coombes, E Schlette, A Ferrajoli, LL Barron, TJ Kipps, L Rassenti, S Faderl, H Kantarjian, LV Abruzzo
Blood 2008
Biologic prognostic markers and their application in clinical trials and management of chronic lymphocytic leukaemia patients
T Butler, JG Gribben
Expert Opinion on Medical Diagnostics 2008
Chronic lymphocytic leukaemia: An immunobiology approach
E Kostareli, T Smilevska, K Stamatopoulos, A Kouvatsi, A Anagnostopoulos
Srpski arhiv za celokupno lekarstvo 2008
Chronic lymphocytic leukemia patients exposed to ionizing radiation due to the Chernobyl NPP accident—With focus on immunoglobulin heavy chain gene analysis
I Abramenko, N Bilous, A Chumak, E Davidova, I Kryachok, Z Martina, S Nechaev, I Dyagil, D Bazyka, V Bebeshko
Leukemia Research 2008
MYC translocation in chronic lymphocytic leukaemia is associated with increased prolymphocytes and a poor prognosis
YO Huh, KI Lin, F Vega, E Schlette, CC Yin, MJ Keating, R Luthra, LJ Medeiros, LV Abruzzo
British Journal of Haematology 2008
Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome
D Rossi, M Cerri, D Capello, C Deambrogi, FM Rossi, A Zucchetto, LD Paoli, S Cresta, S Rasi, V Spina, S Franceschetti, M Lunghi, C Vendramin, R Bomben, A Ramponi, G Monga, A Conconi, C Magnani, V Gattei, G Gaidano
British Journal of Haematology 2008
Human leukocyte antigen class II allele association to disease progression in Iranian patients with chronic lymphocytic leukemia
M Hojjat-Farsangi, M Jeddi-Tehrani, AA Amirzargar, SM Razavi, RA Sharifian, H Rabbani, F Shokri
Human Immunology 2008
Distinctive IgVH gene segments usage and mutation status in Chinese patients with chronic lymphocytic leukemia
L Chen, Y Zhang, W Zheng, Y Wu, C Qiao, L Fan, W Xu, J Li
Leukemia Research 2008
Dasatinib sensitizes primary chronic lymphocytic leukaemia lymphocytes to chlorambucil and fludarabinein vitro
L Amrein, TA Hernandez, C Ferrario, J Johnston, SB Gibson, L Panasci, R Aloyz
British Journal of Haematology 2008
Molecular Profiling in CLL
JG Gribben
Hematology 2008
Molecular genetic characterization reveals new subsets of mantle cell lymphoma
EF Thelander, R Rosenquist
Leukemia & Lymphoma 2008
Long-term molecular remissions in patients with indolent lymphoma treated with rituximab as a single agent or in combination with interferon alpha-2a: A randomized phase II study from the Nordic Lymphoma Group
E Kimby, J Jurlander, C Geisler, H Hagberg, H Holte, T Lehtinen, B Östenstad, M Hansen, A Österborg, O Lindén, C Sundström, OB Gr
Leukemia & Lymphoma 2008
Mutated IgHV1-69 gene usage represents a distinct subgroup associated with indolent disease in chronic lymphocytic leukemia
L Galligan, MA Catherwood, C Matthews, TC Morris, HD Alexander
Leukemia & Lymphoma 2008
Chronic lymphocytic leukemia with mutated IgVH1-69 usage: A distinct CLL subgroup with more indolent behavior?
EM Hartmann, A Rosenwald
Leukemia & Lymphoma 2008
Molecular and transcriptional characterization of 17p loss in B-cell chronic lymphocytic leukemia
S Fabris, L Mosca, K Todoerti, G Cutrona, M Lionetti, D Intini, S Matis, M Colombo, L Agnelli, M Gentile, M Spriano, V Callea, G Festini, S Molica, GL Deliliers, F Morabito, M Ferrarini, A Neri
Genes, Chromosomes and Cancer 2008
Monoclonal B-Cell Lymphocytosis and Chronic Lymphocytic Leukemia
AC Rawstron, FL Bennett, SJ O'Connor, M Kwok, JA Fenton, M Plummer, R Tute, RG Owen, SJ Richards, AS Jack, P Hillmen
New England Journal of Medicine 2008
Hematopathology
F Naeim
Hematopathology 2008
Novel genomic alterations and clonal evolution in chronic lymphocytic leukemia revealed by representational oligonucleotide microarray analysis (ROMA)
V Grubor, A Krasnitz, JE Troge, JL Meth, B Lakshmi, JT Kendall, B Yamrom, G Alex, D Pai, N Navin, LA Hufnagel, YH Lee, K Cook, SL Allen, KR Rai, RN Damle, C Calissano, N Chiorazzi, M Wigler, D Esposito
Blood 2008
Chronic Lymphocytic Leukemia: The Role of MBL
P Ghia, A Rawstron
Chronic Lymphocytic Leukemia: The Role of MBL 2008
Use of V H, D and J H immunoglobulin gene segments in Brazilian patients with chronic lymphocytic leukaemia (CLL)
BJ Pimentel, CG Stefanoff, AS Moreira, HN Seuánez, IR Zalcberg
Genetics and molecular biology 2008
Molecular Genetic Pathology
L Cheng, DY Zhang
2008

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 19 patents
290 readers on Mendeley
See more details